Skip to main content
OpenTrials
Completed

NCT Number: NCT01057966

Bioavailability of Nutrients Contained in Softgel Capsules vs Tablets

This study is a comparison of the bioavailability of nutrients contained in softgel capsules vs tablets.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vision

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Contact Alcon Call Center For Trial Locations

Fort Worth, Texas, 76134, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 35
  • Body Mass Index (BMI) 21-27 kg/m2
  • Must be able to give written informed consent
  • Subjects must be willing to comply with all study requirements.
  • Subjects must understand, sign and be given a copy of the written Informed Consent form.

Exclusion criteria

  • Subjects for whom both eyes do not meet all inclusion criteria and either eye meets exclusion criteria
  • Subjects who are pregnant, lactating or planning to be pregnant during the course of the study
  • Subjects with known sensitivity to planned study concomitant medications
  • Subjects participating in any other ophthalmic drug or device clinical trial within 30 days of this clinical investigation.
  • Use of ocular drugs, other than study medications, during the study and within 14 days prior to study entry or any other ocular medication

Treatment and study plan

ICAPS Eye Vitamin and Mineral Supplement - Softgel (full strength)

Dietary Supplement

Single full strength dose capsule taken one time

ICAPS Eye Vitamin and Mineral Supplement - Softgel (half strength)

Dietary Supplement

Single half strength dose capsule taken one time

ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets (full strength)

Dietary Supplement

Single, full strength dose tablet taken one time

Primary outcomes

  1. Bioavailability of nutrients

    Time frame: 1 week for each treatment cross-over period

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jan 28, 2010
Registry last updated
Feb 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.